Skip to content

Prime Medicine PRME Prepaid expenses

Prepaid expenses at other companies

Eli Lilly logo
Eli LillyLLY
Regenxbio logo
RegenxbioRGNX
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Wave Life Sciences logo
Wave Life SciencesWVE

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's prepaid expenses?
Prime Medicine (PRME) reported prepaid expenses of $1.97M in Q1 2026.
How has Prime Medicine's prepaid expenses changed year-over-year?
Prime Medicine's prepaid expenses decreased by 33.1% year-over-year, from $2.95M to $1.97M.
What is the long-term trend for Prime Medicine's prepaid expenses?
Over 3 years (2022 to 2025), Prime Medicine's prepaid expenses has grown at a 6.2% compound annual growth rate (CAGR), from $2.45M to $2.94M.